[PDF] Top 20 El lenguaje como una estrategia para el aprendizaje de los temas del currículo de las ciencias
Has 10000 "El lenguaje como una estrategia para el aprendizaje de los temas del currículo de las ciencias" found on our website. Below are the top 20 most common "El lenguaje como una estrategia para el aprendizaje de los temas del currículo de las ciencias".
Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review
... for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease”, no consensus was achieved for statements on vitamin D de- ...GD1 ... See full document
10
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy
... of patients with GD1 and bone involvement. Thirty- two GD1 patients with skeletal manifestations were evalu- ated for HRQOL before and after biweekly imiglucerase (at 60 U/ ...in patients with ... See full document
6
Gene variants of osteoprotegerin, estrogen-, calcitonin- and vitamin D-receptor genes and serum markers of bone metabolism in patients with Gaucher disease type 1
... The manuscript has been checked for spelling and grammar by a professional English editing service. We thank Mrs Adriana Degreif for excellent technical assistance. This work was supported by a research grant from SC ... See full document
9
Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease
... the Gaucher Registry ...for patients with GD I and a comparison of different dosage ...literature review identified three studies that reported economic evaluations all of which produced very high ... See full document
39
Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease
... Abstract: Gaucher disease (GD) is a heritable storage disorder caused by functional defects of the lysosomal acid β-glucosidase and the accumulation of glucosylceramide within macro- phages, resulting in ... See full document
38
Ethnic diversity outpatient clinic in paediatrics
... mellitus type 1, metabolic disease (inborn errors of metabolism), chronic abdominal pain, nephrological disorders, chronic headache, severe obe- sity or epilepsy, who were treated in ... See full document
7
A Review of Endocrine Disorders in Thalassaemia
... most patients have ferritin levels close to 2000 ...the disease are ...of patients [5,27,31,66] suggesting insensitivity of the thyroid gland to iron ...thyroid disease may have a fairly ... See full document
440
Long-term effect of imiglucerase in Latin American children with Gaucher disease type 1: lessons from the International Collaborative Gaucher Group Gaucher Registry
... ICGG Gaucher Registry as of 7 October 2011. The ICGG Gaucher Registry is an ongoing, observational database that tracks the natural history and outcomes of patients with GD, regardless of symptoms or ... See full document
11
Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1
... Gaucher Disease (GD) is an inherited lysosomal storage disease, attributable to glucocerebrosidase enzyme de- ficiency; in rare cases, the absence of saposin C, an ac- tivator of glucocerebrosidase, ... See full document
9
A new framework for evaluating the health impacts of treatment for Gaucher disease type 1
... complex disease and does not capture disease progression for patients not re- ceiving ...the Gaucher Disease Severity Index-Type I [33], may not be as readily available or easy ... See full document
30
Dental profile of patients with Gaucher disease
... of patients who present some features in childhood and who demonstrate at least one neurological ...of Gaucher disease were rec- ognized in the Norbottnian-Vesterbottnian territories in northern ... See full document
8
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
... artery disease received 500 mg oral ALC and 200 mg oral α -lipoic acid twice daily and their effect on vascular function and blood pressure were assessed. The trial consisted of two 8-week treatment periods ... See full document
53
<p>Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?</p>
... with metabolic syndrome have up to ...have metabolic syndrome. 8,9 Both metabolic syn- drome and diabetes mellitus (DM) are on the rise as a pandemic global health ...10 Metabolic syndrome is ... See full document
15
Gaucher’s Disease and Fatal Hepatic Fibrosis Despite Prolonged Enzyme Replacement Therapy
... Gaucher’s disease group has used vari- ous decisional criteria for ERT, including osteonecro- sis, painful bone or abdominal episodes, heavy asthenia, major splenomegaly, growth retardation, frequent bruising, ... See full document
10
Metabolic Syndrome in Type 1 Diabetes
... Cardiovascular Disease in Patients With Type 1 Diabetes in the ...with type 1 diabetes (n = 7,479) and five age- and sex-matched subjects without diabetes (n = 38,116) and free ... See full document
Links between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis in Alzheimer’s Disease
... as metabolic sensors for the calorie sensitive Sirt 1 gene involved in DNA repair [165] [189] ...of metabolic syndrome, NAFLD [45] [165] [189] and other associated diseases such as stroke [380] ... See full document
122
Large animal models of rare genetic disorders: sheep as phenotypically relevant models of human genetic disease
... of disease manifestations at both the genotypic and phenotypic level allows for greater in- sights into disease ...genetic disease in sheep is a first step towards the possibility of successfully ... See full document
9
Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in Egypt
... phenotype. Patients, their geno- type, and clinical characteristics are presented in ta- bles e-1 and ...3 patients were L444P homozygous: 1 patient was D409H homozygous, and the ... See full document
219
Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
... GD1 patients led to only minor reductions and switch- ing patients from ERT to miglustat tended to be associ- ated with stable or increasing plasma ...for disease burden in GD1 [31], but does not ... See full document
11
Switching from imiglucerase to miglustat for the treatment of French patients with Gaucher disease type 1: a case series
... our patients showed improvements in key hematological and visceral disease parameters during initial 3 to 6 years of ...three patients showed maintenance of plate- lets, hemoglobin and plasma ... See full document
8
Related subjects